Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
par Saini, Kamal ;Lanza, Carlo;Romano, Marco;de Azambuja, Evandro ;Cortes, Javier;de las Heras, Begoña;de Castro, Javier;Lamba Saini, Monika;Loibl, Sibylle;Curigliano, Giuseppe;Twelves, Chris;Leone, Manuela;Patnaik, Mrinal M.M.
Référence British Journal of Cancer
Publication Publié, 2020
Référence British Journal of Cancer
Publication Publié, 2020
Article révisé par les pairs
Résumé : | Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course of COVID-19. |